AU2001248769A1 - Time-release coated solid compositions for oral administration - Google Patents

Time-release coated solid compositions for oral administration

Info

Publication number
AU2001248769A1
AU2001248769A1 AU2001248769A AU4876901A AU2001248769A1 AU 2001248769 A1 AU2001248769 A1 AU 2001248769A1 AU 2001248769 A AU2001248769 A AU 2001248769A AU 4876901 A AU4876901 A AU 4876901A AU 2001248769 A1 AU2001248769 A1 AU 2001248769A1
Authority
AU
Australia
Prior art keywords
time
oral administration
solid compositions
release coated
coated solid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001248769A
Other languages
English (en)
Inventor
Kazuhiro Sako
Toyohiro Sawada
Shunsuke Watanabe
Tatsunobu Yoshioka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of AU2001248769A1 publication Critical patent/AU2001248769A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001248769A 2000-04-17 2001-04-16 Time-release coated solid compositions for oral administration Abandoned AU2001248769A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19808600P 2000-04-17 2000-04-17
US60198086 2000-04-17
PCT/JP2001/003229 WO2001078686A1 (fr) 2000-04-17 2001-04-16 Compositions solides enrobees a liberation decalee dans le temps

Publications (1)

Publication Number Publication Date
AU2001248769A1 true AU2001248769A1 (en) 2001-10-30

Family

ID=22731930

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001248769A Abandoned AU2001248769A1 (en) 2000-04-17 2001-04-16 Time-release coated solid compositions for oral administration

Country Status (4)

Country Link
US (2) US20020028240A1 (fr)
EP (1) EP1275381A4 (fr)
AU (1) AU2001248769A1 (fr)
WO (1) WO2001078686A1 (fr)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020028240A1 (en) * 2000-04-17 2002-03-07 Toyohiro Sawada Timed-release compression-coated solid composition for oral administration
US20080199522A1 (en) * 2001-04-12 2008-08-21 Astellas Pharma, Inc. Timed-release compression-coated solid composition for oral administration
BR0213591A (pt) * 2001-09-28 2004-08-31 Mcneil Ppc Inc Composição comestìvel e forma de dosagem compreendendo uma parte externa comestìvel
US7217381B2 (en) 2001-09-28 2007-05-15 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US6837696B2 (en) * 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
US20030228368A1 (en) * 2001-09-28 2003-12-11 David Wynn Edible solid composition and dosage form
US6982094B2 (en) * 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US20030229158A1 (en) * 2001-09-28 2003-12-11 Chen Jen Chi Polymer composition and dosage forms comprising the same
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
KR20050065550A (ko) * 2002-09-26 2005-06-29 아스텔라스세이야쿠 가부시키가이샤 약물 흡수성 개선제
US20040081695A1 (en) * 2002-09-28 2004-04-29 Sowden Harry S Dosage forms having an inner core and an outer shell
US7807197B2 (en) * 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US20040121010A1 (en) * 2002-10-25 2004-06-24 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
EP1556024A4 (fr) * 2002-10-25 2007-01-17 Collegium Pharmaceutical Inc Compositions a liberation intermittente de milnaciprane
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
WO2004062692A1 (fr) * 2003-01-13 2004-07-29 Solvay Pharmaceuticals B.V. Formulation de substances actives a faible hydrosolubilite
US7442387B2 (en) * 2003-03-06 2008-10-28 Astellas Pharma Inc. Pharmaceutical composition for controlled release of active substances and manufacturing method thereof
CA2523158C (fr) 2003-04-24 2010-11-16 Jagotec Ag Comprime a action retardee et a geometrie de noyau definie
PT1663216E (pt) * 2003-08-29 2012-02-14 Veloxis Pharmaceuticals As Dispersões sólidas que compreendem tacrolímus
ATE473003T1 (de) 2003-08-29 2010-07-15 Lifecycle Pharma As Tacrolimus enthaltende feste dispersionen
US20050118267A1 (en) * 2003-09-19 2005-06-02 Penwest Pharmaceuticals Co. Chronotherapeutic dosage forms
US20050074514A1 (en) * 2003-10-02 2005-04-07 Anderson Oliver B. Zero cycle molding systems, methods and apparatuses for manufacturing dosage forms
EA200600953A1 (ru) * 2003-12-12 2006-10-27 Пенвест Фармасьютикалз Ко. Дозированные формы торсемида пролонгированного высвобождения
US7018653B2 (en) 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
US8067029B2 (en) 2004-01-13 2011-11-29 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US7879354B2 (en) 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US20050202079A1 (en) * 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
KR100598326B1 (ko) * 2004-04-10 2006-07-10 한미약품 주식회사 ＨＭＧ-ＣｏＡ 환원효소 억제제의 경구투여용 서방형 제제및 이의 제조방법
JP5134955B2 (ja) * 2004-09-10 2013-01-30 ヤゴテック アクチエンゲゼルシャフト 活性成分の部位時間制御胃腸放出作用を有する錠剤
DE102004043863A1 (de) * 2004-09-10 2006-03-16 Nitec Pharma Ag Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum
KR20070061578A (ko) * 2004-10-05 2007-06-13 아스텔라스세이야쿠 가부시키가이샤 눈물 및 침 건조증 치료용 의약 조성물
US20090110727A1 (en) * 2004-10-12 2009-04-30 Eisai R & D Management Co., Ltd. Extended release compositions of proton pump inhibitors
US8673352B2 (en) * 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
US20060275513A1 (en) * 2005-06-07 2006-12-07 Gardiner Paul T Diet supplement for burning additional calories, providing sustained energy, supporting weight loss, and/or improving mental focus
DE202006002409U1 (de) 2006-01-18 2006-04-20 Gottlieb Binder Gmbh & Co. Kg Flammhemmender Verschluß
ATE390138T1 (de) * 2006-02-09 2008-04-15 Teva Pharma Dipyridamol enthaltende zusammensetzungen mit verlängerter freisetzung und verfahren zu deren herstellung
US8067033B2 (en) 2007-11-30 2011-11-29 Horizon Pharma Usa, Inc. Stable compositions of famotidine and ibuprofen
CA2671200A1 (fr) * 2006-07-21 2008-01-24 Lab International Srl Systeme de delivrance hydrophile empechant les utilisations abusives
CA2655682A1 (fr) 2006-08-03 2008-02-07 Nitec Pharma Ag Traitement glucocorticoidique a liberation retardee de maladie rhumatoide
US20080241240A1 (en) * 2006-08-24 2008-10-02 Hanall Pharmaceutical Co., Ltd. Combined pharmaceutical formulation with controlled-release comprising dihydropyridine calcium channel blockers and hmg-coa reductase inhibitors
WO2008023869A1 (fr) * 2006-08-24 2008-02-28 Hanall Pharmaceutical Co., Ltd. PRÉPARATION PHARMACEUTIQUE COMBINÉE À LIBÉRATION CONTRÔLÉE COMPRENANT DES INHIBITEURS CALCIQUES À BASE DE DIHYDROPYRIDINE ET DES INHIBITEURS DE HMG-CoA RÉDUCTASE
WO2008081829A1 (fr) 2006-12-27 2008-07-10 Astellas Pharma Inc. Copolymère de méthacrylate d'aminoalkyle e pour maintenir la solubilité d'un médicament faiblement soluble dans l'eau
CA2674039A1 (fr) * 2006-12-28 2008-07-17 Astellas Pharma Inc. Composition pharmaceutique a liberation entretenue de tacrolimus
EP2139466B1 (fr) 2007-03-22 2019-10-23 Neurocentria, Inc. Compositions contenant du magnésium et leur utilisation
US8178118B2 (en) 2007-03-22 2012-05-15 Magceutics, Inc. Magnesium compositions and uses thereof for cognitive function
PL2167033T4 (pl) 2007-05-30 2018-08-31 Veloxis Pharmaceuticals A/S Podawana raz dziennie doustna postać dawkowania zawierająca takrolimus
CN102573496B (zh) * 2009-07-01 2015-08-26 玛格塞蒂克斯公司 缓释镁组合物及其用途
US20110046227A1 (en) * 2009-08-21 2011-02-24 Mutual Pharmaceutical Company, Inc. Methods for concomitant administration of colchicine and a second active agent
ES2591352T3 (es) 2010-02-17 2016-11-28 Veloxis Pharmaceuticals A/S Composición de tacrolimus estabilizada
EP2826468A1 (fr) 2010-12-22 2015-01-21 Purdue Pharma L.P. Formes posologiques à libération contrôlée enchâssées et inviolables
NZ612996A (en) 2010-12-23 2015-05-29 Purdue Pharma Lp Tamper resistant solid oral dosage forms
US20130045273A1 (en) * 2011-08-19 2013-02-21 John Cuomo Methods for using nutritional supplements containing lipoic acids and sulfur containing compounds
EA201500742A1 (ru) 2013-02-05 2015-12-30 Пердью Фарма Л.П. Защищенные от нецелевого использования фармацевтические композиции
AU2014219726B2 (en) * 2013-02-22 2018-03-15 Zeria Pharmaceutical Co., Ltd. Enteric coated tablet
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
SG11201800591TA (en) * 2015-07-30 2018-02-27 Takeda Pharmaceuticals Co Tablet
CA3050696A1 (fr) * 2017-01-20 2018-07-26 Constellation Pharmaceuticals, Inc. Dispersions solides de (r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide
WO2018200885A1 (fr) 2017-04-26 2018-11-01 Neurocentria, Inc. Compositions de magnésium et méthodes d'utilisation

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB986254A (en) * 1962-12-11 1965-03-17 Upjohn Co Coated tablets
CA1146866A (fr) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Procede de production d'un compose pharmaceutique a liberation continue sous forme solide
US4610870A (en) * 1984-10-05 1986-09-09 E. R. Squibb & Sons, Inc. Controlled release formulation
GB8616669D0 (en) * 1986-07-09 1986-08-13 Merk Sharpe & Dohme Ltd Pharmaceutical compositions
US5310572A (en) * 1987-02-03 1994-05-10 Dow Corning Corporation Process for forming a coated active agent-containing article
US4925675A (en) * 1988-08-19 1990-05-15 Himedics, Inc. Erythromycin microencapsulated granules
US4925674A (en) * 1988-08-25 1990-05-15 Himedics, Inc. Amoxicillin microencapsulated granules
EP0546593B1 (fr) * 1991-10-30 1997-09-03 Glaxo Group Limited Compositions multicouches contenant d'antagonistes de l'histamine ou de la sérotonine
PT661045E (pt) * 1992-09-18 2002-11-29 Yamanouchi Pharma Co Ltd Preparacao em hidrogel de libertacao prolongada
US5922352A (en) * 1997-01-31 1999-07-13 Andrx Pharmaceuticals, Inc. Once daily calcium channel blocker tablet having a delayed release core
US5840329A (en) * 1997-05-15 1998-11-24 Bioadvances Llc Pulsatile drug delivery system
US5931381A (en) * 1997-05-23 1999-08-03 Fiedrich; Joachim For radiant floor, wall and ceiling hydronic heating and/or cooling systems using metal plates that are heated or cooled by attached tubing that is fed hot or cold water, techniques of improving performance and avoiding condensation when cooling
US6235311B1 (en) * 1998-03-18 2001-05-22 Bristol-Myers Squibb Company Pharmaceutical composition containing a combination of a statin and aspirin and method
US6248359B1 (en) * 2000-01-05 2001-06-19 Laboratorios Phoenix U.S.A., Inc. Multi-tablet oxybutynin system for treating incontinence
US6277409B1 (en) * 2000-02-11 2001-08-21 Mcneil-Ppc, Inc. Protective coating for tablet
US20020028240A1 (en) * 2000-04-17 2002-03-07 Toyohiro Sawada Timed-release compression-coated solid composition for oral administration
US20080199522A1 (en) * 2001-04-12 2008-08-21 Astellas Pharma, Inc. Timed-release compression-coated solid composition for oral administration

Also Published As

Publication number Publication date
WO2001078686A1 (fr) 2001-10-25
US20020028240A1 (en) 2002-03-07
EP1275381A1 (fr) 2003-01-15
EP1275381A4 (fr) 2007-05-02
US20060292221A1 (en) 2006-12-28

Similar Documents

Publication Publication Date Title
AU2001248769A1 (en) Time-release coated solid compositions for oral administration
AU781269C (en) Pharmaceutical compositions
AU2001250420A1 (en) Pharmaceutical compositions
AU2276801A (en) Extended release oral dosage composition
AU2001274307A1 (en) Pharmaceutical compositions
AU2002222118A1 (en) Pharmaceutical compositions for inhalation
AU2277101A (en) Stable extended release oral dosage composition
AU2115301A (en) Dental compositions
AU3192700A (en) Medicinal compositions
AU3556400A (en) Pharmaceutical compositions
AU2005300A (en) Medicinal compositions
AU2002214324A1 (en) Medicinal compositions
AU4428000A (en) Pulse-delivery oral compositions
AU2001290239A1 (en) Medicinal composition
AU2001225164A1 (en) Compositions with enhanced oral bioavailability
AU2001273919A1 (en) Pharmaceutical compositions
AU6460400A (en) Pharmaceutical compositions
AU2002210433A1 (en) Dental compositions
AU1732401A (en) Medicinal compositions for oral use
AU2001270235A1 (en) Oral compositions
AU2002215114A1 (en) Pharmaceutical compositions for inhalation
AU6460200A (en) Pharmaceutical compositions
AU4085201A (en) Pharmaceutical composition
AU2001290669A1 (en) Oral compositions
AU6460100A (en) Pharmaceutical compositions